Evidence map›Paper›PMID 37522383›Full record

ArticleEMBO molecular medicine2023

Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies.

Alexandra Argyriou, Begum Horuluoglu, Angeles Shunashy Galindo-Feria, Juan Sebastian Diaz-Boada, Merel Sijbranda, Antonella Notarnicola, Lara Dani, Annika van Vollenhoven, Daniel Ramsköld, Inger Nennesmo and 4 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Emerging therapies in idiopathic inflammatory myopathies.Journal of neuromuscular diseases · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Clonally expanded effector CD4Journal for immunotherapy of cancer · 2025
    Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Alexandra Argyriou *Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Begum Horuluoglu *Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2241-5170
Angeles Shunashy Galindo-Feria *Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Juan Sebastian Diaz-BoadaDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Merel SijbrandaDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Antonella NotarnicolaDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Lara DaniDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Annika van VollenhovenDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Daniel RamsköldDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Inger NennesmoDepartment of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden.
Maryam DastmalchiDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Ingrid E LundbergDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Lina-Marcela Diaz-Gallo *Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5688-0102
Karine Chemin *Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2597-7809
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIM) are rare autoimmune systemic diseases characterized by muscle weakness and the presence of muscle-infiltrating T cells. IIM represent a clinical challenge due to heterogeneity of symptoms and variability of response to immunosuppressive treatment. Here, we performed in-depth single-cell sequencing on muscle-infiltrating T cells and peripheral blood memory T cells in six patients with recently diagnosed IIM. We identified tissue resident memory T-cell (T

Indexed as

Autoimmune DiseasesMyositisHumansMusclesT-LymphocytesHOBITidiopathic inflammatory myopathiesmuscleT-cell receptortissue resident memory T cells

Identifiers

PMID37522383
PMCPMC10565639
OpenAlexW4385406013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.